JP2022546538A5 - - Google Patents
Info
- Publication number
- JP2022546538A5 JP2022546538A5 JP2022514012A JP2022514012A JP2022546538A5 JP 2022546538 A5 JP2022546538 A5 JP 2022546538A5 JP 2022514012 A JP2022514012 A JP 2022514012A JP 2022514012 A JP2022514012 A JP 2022514012A JP 2022546538 A5 JP2022546538 A5 JP 2022546538A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- patients
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19195122 | 2019-09-03 | ||
| EP19195122.7 | 2019-09-03 | ||
| PCT/EP2020/074531 WO2021043863A1 (en) | 2019-09-03 | 2020-09-03 | Fusion proteins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546538A JP2022546538A (ja) | 2022-11-04 |
| JP2022546538A5 true JP2022546538A5 (https=) | 2023-09-07 |
| JP7668785B2 JP7668785B2 (ja) | 2025-04-25 |
Family
ID=68062789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514012A Active JP7668785B2 (ja) | 2019-09-03 | 2020-09-03 | 融合タンパク質およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12611440B2 (https=) |
| EP (1) | EP4025591A1 (https=) |
| JP (1) | JP7668785B2 (https=) |
| KR (1) | KR20220054612A (https=) |
| CN (1) | CN114341196B (https=) |
| AU (1) | AU2020342690B2 (https=) |
| BR (1) | BR112022003753A2 (https=) |
| CA (1) | CA3148527A1 (https=) |
| MX (1) | MX2022002628A (https=) |
| WO (1) | WO2021043863A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4301394A1 (en) * | 2021-03-03 | 2024-01-10 | Synklino ApS | Compositions for ex vivo organ care |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9078428B2 (en) | 2005-06-28 | 2015-07-14 | Transmedics, Inc. | Systems, methods, compositions and solutions for perfusing an organ |
| EP2038302B1 (en) | 2006-07-03 | 2012-10-24 | INAGEN ApS | Immunotoxins for the treatment of diseases related to cmv infection |
| US8141744B2 (en) * | 2008-10-23 | 2012-03-27 | Gojo Industries, Inc. | Foam dispenser having selectively pressurized cartridge |
| CN102154355A (zh) * | 2011-01-06 | 2011-08-17 | 武汉大学 | 一种重组免疫毒素ccl25-pe38基因及制备方法和应用 |
| RU2616245C2 (ru) | 2015-12-29 | 2017-04-13 | Сейфаддин Гашим Оглы Марданлы | Композиция для профилактики заболеваний, вызываемых цитомегаловирусной инфекцией |
-
2020
- 2020-09-03 EP EP20764110.1A patent/EP4025591A1/en active Pending
- 2020-09-03 CN CN202080062014.XA patent/CN114341196B/zh active Active
- 2020-09-03 JP JP2022514012A patent/JP7668785B2/ja active Active
- 2020-09-03 BR BR112022003753A patent/BR112022003753A2/pt unknown
- 2020-09-03 KR KR1020227008279A patent/KR20220054612A/ko active Pending
- 2020-09-03 AU AU2020342690A patent/AU2020342690B2/en active Active
- 2020-09-03 CA CA3148527A patent/CA3148527A1/en active Pending
- 2020-09-03 US US17/639,618 patent/US12611440B2/en active Active
- 2020-09-03 WO PCT/EP2020/074531 patent/WO2021043863A1/en not_active Ceased
- 2020-09-03 MX MX2022002628A patent/MX2022002628A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3705732B2 (ja) | 新規なポリペプチド、その製造方法、そのポリペプチドをコードするｄｎａ、そのｄｎａからなるベクター、そのベクターで形質転換された宿主細胞 | |
| CN101553243B (zh) | 组织损伤修复中的基质细胞衍生因子1的蛋白酶抗性突变体 | |
| CN113173995B (zh) | 一种结合冠状病毒的双特异性抗体 | |
| JPWO2019156137A5 (https=) | ||
| EP0750037A2 (en) | TNF-convertase and method measuring inhibition of TNF convertase | |
| JP2022546538A5 (https=) | ||
| JP2009540842A5 (https=) | ||
| AU2005298245B2 (en) | A thymus-specific protein | |
| JPH06501620A (ja) | 可溶性マンノース受容体ペプチド | |
| CN108840950A (zh) | 一种由猪白细胞介素2、猪干扰素γ和猪干扰素α组成的融合蛋白及其制备方法 | |
| JP2009542631A (ja) | 自己免疫疾患、アレルギー性疾患及び炎症性疾患治療用薬剤組成物、並びにその伝達方法 | |
| CN114206944A (zh) | 用于治疗cmv感染相关疾病的融合毒素蛋白 | |
| CN108840945A (zh) | 猪白蛋白-干扰素α-白介素2融合蛋白、制备方法及其编码基因、一种猪长效干扰素 | |
| JP7229519B2 (ja) | 血管新生促進剤 | |
| CN108295242B (zh) | 用于预防和/或治疗银屑病药物组合物、cd317胞外段蛋白的应用 | |
| JP7668785B2 (ja) | 融合タンパク質およびその使用 | |
| JP5385611B2 (ja) | Ｐｆ４とｒａｎｔｅｓとの相互作用に対するアンタゴニスト | |
| JP2024508753A (ja) | 製造及び療法への使用のために改変されたｄｎａｓｅ１－ｌｉｋｅ２ | |
| CN107446024A (zh) | 一种可拮抗ddx3蛋白rna结合活性的多肽dip‑13及其应用 | |
| CN102176922A (zh) | 包含结合于EBV(Epstein-Barr病毒)蛋白BARF1的抗体的药物组合物 | |
| CN117964777A (zh) | 一种接近天然分子的多肽融合分子 | |
| CN117126295B (zh) | 一种基于cd24和ace2的双功能融合蛋白 | |
| JP2022502081A (ja) | 遺伝子操作された微生物ならびにそれを作製および使用する方法 | |
| CN111233998A (zh) | 一种犬干扰素CaIFN-λ突变体及其应用 | |
| US20250179152A1 (en) | Sars-cov-2 neutralizing synthetic proteins |